RiverVest

Dec 20, 2011
Bard Acquires Lutonix, Inc.
Nov 22, 2011
Pfizer to Acquire Excaliard Pharmaceuticals
Oct 26, 2011
3,000+ Patient Meta-Analysis Reinforces Importance of Platelet Reactivity Testing to Aid in Risk Assessment
Sep 29, 2011
Otonomy Presents Positive New Findings from Phase 1b Study of OTO-104 in Ménière’s Disease at International Conference

RiverVest Venture Partners® is a venture capital firm focused on identifying and shaping early-stage life science companies to create significant shareholder value. With hands-on, high-level expertise and financial resources, RiverVest supports entrepreneurs by helping them achieve near-term objectives that position their companies for exit.

Case Study:

VC Partner as Sounding Board

Salient Surgical Technologies, Inc., founded as TissueLink Medical, Inc. in 1999, has successfully achieved market acceptance and strong revenue growth. But it took steady leadership and some skillful maneuvering to manage the inevitable bumps along the way. Read more >

“To have a trusted advisor — someone I can count on no matter how difficult the conversation? That’s worth its weight in gold!” — Joe Army, CEO – Salient Surgical Technologies, Inc.